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Abstract: The current research work was aimed to investigate the impact of The Trivedi Effect® - Energy of 
Consciousness Healing Treatment (Biofield Energy Healing) on the structural properties and isotopic abundance ratio 
(PM+1/PM) of magnesium gluconate using LC-MS and NMR spectroscopy. Magnesium gluconate was divided into two 
parts. One part was denoted as the control, while the another part was defined as The Trivedi Effect
®
 Treated sample, 
which received the Biofield Energy Healing Treatment remotely from eighteen renowned Biofield Energy Healers. The 
total ion chromatogram of the control sample showed two peaks at Rt of 1.81 and 2.06 min, whereas the treated sample 
displayed peaks at Rt of 1.79 and 2.04 min. The ESI-MS spectra of the control and the treated samples revealed the 
presence of the mass for magnesium gluconate ion in two forms at m/z 447 (adduct form with methanol) and 415 
(protonated ion) in positive ionization mode. But, it showed the mass for the gluconate ion at m/z 195 in the negative 
ionization mode. The fragmentation pattern of magnesium gluconate in the treated sample was notably altered compared 
with the control sample. The proton and carbon signals for CH, CH2 and CO groups in the proton and carbon NMR 
spectra were found almost similar for the control and treated samples. The LC-MS based isotopic abundance ratio 
analysis indicated that the PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) in the treated magnesium gluconate ion at 
m/z 415 was significantly decreased by 79.24% compared with the control sample. Similarly, the isotopic abundance 
ratio of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O) in the gluconate ion was decreased by 6.62% in the treated sample 
compared with the control sample. The treated magnesium gluconate might be beneficial in the nutraceutical and/or 
pharmaceutical industries for designing various forms of formulations, which could be providing better therapeutic 
response against various diseases such as diabetes mellitus, allergy, aging, inflammatory diseases, immunological 
disorders, and other chronic infections. Consequently, The Trivedi Effect
®
 - Energy of Consciousness Healing Treated 
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magnesium gluconate would be more helpful for understanding the enzymatic reactions as well as assist in the designing 
of the novel potent enzyme inhibitors by applying its kinetic isotope effects. 
Keywords: Biofield Energy Healing Treatment, Energy of Consciousness Healing Treatment, Biofield Energy Healers,  
The Trivedi Effect
®
, Magnesium Gluconate, LC-MS, NMR, Isotopic Abundance Ratio, Isotope Effects 
 
1. Introduction 
Magnesium ion (Mg
2+
) is a major intracellular divalent 
cation and an essential mineral for several enzymes, DNA 
and RNA synthesis, reproduction and protein synthesis. It is 
also a vital coherent controller of glycolysis and the Krebs 
cycle [1, 2]. Magnesium gluconate (C12H22MgO14) is the 
organometallic salt of magnesium with gluconic acid 
produced from glucose catalyzed by glucose oxidase [3]. 
Magnesium gluconate is found to be a more powerful 
antioxidant than other magnesium salts and it is useful for the 
prevention and treatment of many diseases such as 
cardiovascular diseases, diabetes mellitus, allergy, 
inflammatory diseases, immunological disorders, 
Alzheimer’s disease, asthma, pre-eclampsia and eclampsia, 
cancer, etc. [4-8]. It can be used as neuroprotective [9], for 
the treatment of oxidative stress induced 
ischemia/reperfusion injury [10] and also labor in women 
arrested initially with intravenous therapy as an oral tocolytic 
agent [11]. Magnesium gluconate showed the highest 
bioavailability and most physiologically acceptable salt 
among other magnesium salts like chloride, sulfate, 
carbonate, acetate, citrate, lactate, aspartate, etc. [8, 12]. 
Therefore, magnesium gluconate was considered as one of 
the components in a novel proprietary herbomineral 
formulation for the source of magnesium ion. This 
herbomineral formulation which is designed as nutraceutical 
supplement can be used for the prevention and treatment of 
various human diseases. 
Since ancient times, many different cultures, religions 
and systems of belief have recognized a living force that 
preserves and inhabits every living organism. This force is 
the source of ‘life’ and has been called various names, 
such as prana by the Hindus, qi or chi by the Chinese, and 
ki by the Japanese. This is believed to co-relate with the 
soul, spirit and mind. This hypothetical vital force has 
been scientifically evaluated and is now considered the 
Bioenergetics Field. The Biofield Energy is a dynamic 
electromagnetic field surrounding the human body, 
resulting from the continuous emission of low-level light, 
heat, and acoustical energy from the body. Biofield 
Energy is infinite, para dimensional and can freely flow 
between the human and environment [13, 14]. So, a 
human has the ability to harness energy from the 
ionosphere of the earth, the “universal energy field”, and 
transmit it to any living organism (s) or nonliving object 
(s) around the globe. The object or recipient always 
receives the energy and responds in a useful way. This 
process is known as The Trivedi Effect
®
 - Biofield Energy 
Healing Treatment [15, 16]. Biofield (Putative Energy 
Field) based Energy Therapies are used worldwide to 
promote health and healing. The National Center of 
Complementary and Integrative Health (NCCIH) has 
recognized and accepted Biofield Energy Healing as a 
Complementary and Alternative Medicine (CAM) health 
care approach in addition to other therapies, medicines 
and practices such as natural products, deep breathing, 
yoga, Tai Chi, Qi Gong, chiropractic/osteopathic 
manipulation, meditation, massage, special diets, 
homeopathy, progressive relaxation, guided imagery, 
acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, cranial 
sacral therapy and applied prayer (as is common in all 
religions, like Christianity, Hinduism, Buddhism and 
Judaism) [17]. Biofield Energy Treatment (The Trivedi 
Effect
®
) has been extensively studied with significant 
outcomes in many scientific fields such as agriculture [18-
20], biotechnology [21-23], materials science [24-28], 
pharmaceutical sciences [29-31], medical science [32, 33], 
and microbiology [34-36]. Literature demonstrated that 
Biofield Energy Healing Treatment (The Trivedi Effect
®
) 
might be an alternative method for increasing or 
decreasing the natural isotopic abundance ratio of the 
substances [37, 38]. The stable isotope ratio analysis has 
the wide applications in several scientific fields for 
understanding the isotope effects resulting from the 
variation of the isotopic composition of the molecule [39, 
40]. Conventional mass spectrometry (MS) techniques 
such as liquid chromatography - mass spectrometry (LC-
MS), gas chromatography - mass spectrometry (GC-MS) 
are widely used for isotope ratio analysis with sufficient 
precision [41]. Hence, LC-MS and NMR (Nuclear 
Magnetic Resonance) were used in this study to 
characterize the structural properties of the Biofield 
Energy Treated and untreated magnesium gluconate 
qualitatively for the purpose of the pharmaceutical and 
nutraceutical industrial applications. Consequently, LC-
MS based isotopic abundance ratio analysis of PM+1/PM 
(
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) in both of the 
Biofield Energy Treated and untreated samples was 
targeted to evaluate the influence of Biofield Energy 
Healing Treatment on the isotopic abundance ratio in 
magnesium gluconate. 
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2. Materials and Methods 
2.1. Chemicals and Reagents 
Magnesium gluconate hydrate was procured from Tokyo 
Chemical Industry Co., Ltd. (TCI), Japan. All other 
chemicals used in the experiment were of analytical grade 
available in India. 
2.2. Energy of Consciousness Treatment Strategies 
Magnesium gluconate was one of the components of the 
new proprietary herbomineral formulation, which was 
developed by our research team and was used per se as the 
test compound for the current study. The test compound 
was divided into two parts. One part of the test compound 
did not receive any sort of treatment and defined as 
untreated or control magnesium gluconate sample. 
Consequently, another part of the test compound was 
treated with The Trivedi Effect
®
 - Energy of 
Consciousness Healing Treatment remotely by eighteen 
renowned Biofield Energy Healers and defined as Biofield 
Energy Treated magnesium gluconate. Eleven of the 
Biofield Energy Healers were located in the U. S. A., four 
in Canada, one in Ireland, one in the United Kingdom, and 
one in Russia performed the Biofield Energy Treatment on 
the test compound that was located in the research 
laboratory of GVK Biosciences Pvt. Ltd., Hyderabad, 
India. The Biofield Energy Treatment was provided for 5 
minutes through the Healer’s Unique Energy Transmission 
process remotely to the test compound, which was kept 
under laboratory conditions. None of the Biofield Energy 
Healers in this study visited the laboratory in person, nor 
had any contact with the compounds. Similarly, the 
control compound was subjected to a “sham” healer for 5 
minutes, under the same laboratory conditions. The sham 
healer did not have any knowledge about the Biofield 
Energy Treatment. After that, the Biofield Energy Treated 
and untreated samples were kept in similar sealed 
conditions. The control and Biofield Energy Treated 
samples were analyzed by LC-MS and NMR 
spectroscopy. 
2.3. Characterization 
2.3.1. Liquid Chromatography-Mass Spectrometry  
(LC-MS) Analysis 
Liquid chromatography was accomplished using The 
Waters
®
 ACQUITY UPLC, Milford, MA, USA equipped 
with a binary pump (The Waters
®
 BSM HPLC pump), 
autosampler, column heater and a photo-diode array (PDA) 
detector. The column used for the study was a reversed 
phase Acquity BEH shield RP C18 (150 X 3.0 mm, 2.5 
µm). The column temperature was kept constant at 40°C. 
The mobile phase was 2mM ammonium acetate in water 
as mobile phase A and acetonitrile as mobile phase B. 
Chromatographic separation was achieved with the 
following gradient program: 0 minute - 5%B; 1 minute - 
5%B; 15 minutes - 97%B; 20 minutes - 97%B; 21 minutes 
- 5%B; 25 minutes - 5%B. The flow rate was at a constant 
flow rate of 0.4 mL/minutes. The control and Biofield 
Energy Treated samples were dissolved in a mixture of 
water and methanol (60:40 v/v) to prepare a 1 mg/mL 
stock solution. An aliquot of 2 µL of the stock solution 
was used for analysis by LC-ESI-MS and the total run 
time was 25 minutes. 
Mass spectrometric analysis was accompanied on a 
Triple Quad (Waters Quattro Premier XE, USA) mass 
spectrometer equipped with an electrospray ionization 
(ESI) source with the following parameters: electrospray 
capillary voltage 3.5 kV; source temperature 100°C; 
desolvation temperature 350°C; cone voltage 30 V; 
desolvation gas flow 1000 L/h and cone gas flow 60 L/h. 
Nitrogen was used in the electrospray ionization source. 
The multiplier voltage was set at 650 V. LC-MS was taken 
in positive and negative ionization mode and with the full 
scan (m/z 50-1400). The total ion chromatogram, peak 
area% and mass spectrum of the individual peak (appeared 
in LC) were recorded. 
2.3.2. Isotopic Abundance Ratio Analysis 
The isotopic abundance ratio of the control and Biofield 
Energy Treated magnesium gluconate was performed. The 
natural abundance of each isotope can be predicted from the 
comparison of the height of the isotope peak with respect to 
the base peak, i.e. relative abundance in the mass spectra [37, 
38, 42, 43]. The natural isotopic abundance of the elements 
are obtained from several literatures [43-45] are presented in 
Table 1. 
Table 1. The isotopic composition (the natural isotopic abundance) of the 
elements. 
Element (A) Symbol Mass 
% Natural 
Abundance 
A + 1 Factor A + 2 Factor 
Hydrogen 1H 1 99.9885   
 2H 2 0.0115 0.015nH  
Carbon 12C 12 98.892   
 13C 13 1.108 1.1nC  
Oxygen 16O 16 99.762   
 17O 17 0.038 0.04nO  
 18O 18 0.200  0.20nO 
Magnesium 24Mg 24 78.99   
 25Mg 25 10.00 12.66 nMg  
 26Mg 26 11.01  13.94 nMg 
A: Element; n: no of H, C, O, Mg, etc. 
The following method was used for calculating the 
isotopic abundance ratio: 
PM stands for the relative peak intensity of the parent 
molecular ion [M
+
] expressed in percentage. In other way, it 
indicates the probability to have A element (for e.g. 
12
C, 
1
H, 
16
O, 
24
Mg, etc.) contributions to the mass of the parent 
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molecular ion [M
+
]. 
PM+1 represents the relative peak intensity of the isotopic 
molecular ion [(M+1)
+
] expressed in percentage 
= (no. of 
13
C x 1.1%) + (no. of 
2
H x 0.015%) + (no. of 
17
O 
x 0.04%) + (no. of 
25
Mg x 12.66%) 
i.e. the probability to have A + 1 element (for e.g. 
13
C, 
2
H, 
25
Mg, etc.) contributions to the mass of the isotopic 
molecular ion [(M+1)
+
] 
PM+2 represents the relative peak intensity of the isotopic 
molecular ion [(M+2)
+
] expressed in the percentage 
= (no. of 
18
O x 0.20%) + (no. of 
26
Mg x 13.94%) 
i.e. the probability to have A + 2 elements (for e.g.
 18
O,
 
26
Mg, etc.) contributions to the mass of isotopic molecular 
ion [(M+2)
+
] 
Isotopic abundance ratio (IAR) for A + 1 elements = PM + 
1/PM 
Similarly, isotopic abundance ratio of A + 2 elements = 
PM+2/PM 
Percentage (%) change in isotopic abundance ratio = 
[(IARTreated - IARControl)/ IARControl) x 100]            (1) 
Where, IARTreated is isotopic abundance ratio in the treated 
magnesium gluconate sample and IARControl is isotopic 
abundance ratio in the control magnesium gluconate sample. 
2.3.3. Nuclear Magnetic Resonance (NMR) Analysis 
1
H NMR spectra were recorded in a 400 MHZ VARIAN 
FT-NMR spectrometer at room temperature. Data refer to 
solutions in D2O with the residual solvent protons as 
internal references. 
1
H NMR multiplicities were 
designated as singlet (s), doublet (d), triplet (t), multiplet 
(m), and broad (br). 
13
C NMR spectra were measured at 
100 MHz on a VARIAN FT-NMR spectrometer at room 
temperature. Chemical shifts (δ) were in parts per million 
(ppm) relative to the solvent’s residual proton chemical 
shift (D2O, δ = 4.65 ppm) and solvent’s residual carbon 
chemical shift (D2O, δ = 0 ppm) [46]. 
3. Results and Discussion 
3.1. Liquid Chromatography-Mass Spectrometry (LC-MS) 
Analysis 
The total ion chromatograms (TIC) of the control and 
Biofield Energy Treated magnesium gluconate are shown in 
Figure 1. The TIC of the control magnesium gluconate 
showed two peaks at retention time (Rt) of 1.81 and 2.06 
minutes with the peak area% of 61.22% and 38.78%, 
respectively in the chromatogram. Similarly, the 
chromatogram of the Biofield Energy Treated magnesium 
gluconate exhibited two peaks at Rt of 1.79 and 2.04 min 
with the peak area% of 61.77% and 38.23%, respectively. 
The results indicated that Biofield Energy did not show any 
impact in the alteration of the polarity/affinity of the Biofield 
Energy Treated magnesium gluconate compared with the 
control sample. 
 
Figure 1. Total ion chromatograms (TIC) of the control and Biofield Energy Treated magnesium gluconate using The Waters® ACQUITY UPLC. 
The ESI-MS spectra of both the control and Biofield 
Energy Treated samples are presented in Figure 2 and 3. The 
ESI-MS (+ve ion mode) spectra of both the control and 
Biofield Energy Treated magnesium gluconate at Rt of 2.1 
minutes (Figure 2) indicated the presence of the mass for 
protonated magnesium gluconate ion at m/z 415 [M + H]
+
 
(calculated for C12H23MgO14
+
, 415). Adduct of the 
magnesium gluconate with methanol (pseudo molecular ion) 
was found at m/z 447 [M + CH3OH + H]
+
 (calculated for 
C13H27MgO15
+
, 447). Adducts formation, either with solvents 
(i.e. methanol), alkali or metal ions or other contaminating 
components are frequently observed in the ESI analysis [47, 
48]. 
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Figure 2. The ESI-MS (+ve ion mode) spectra of the control and Biofield Energy Treated magnesium gluconate. 
 
Figure 3. The ESI-MS (-ve ion mode) spectra of the control and Biofield Energy Treated magnesium gluconate. 
The pseudo molecular ion magnesium gluconate at m/z 
447 displayed 100% relative intensity in the control sample, 
while the fragment ion peak at m/z 100 exhibited the 100% 
relative peak intensity in the Biofield Energy Treated sample. 
The notable fragment ion peaks in the lower region of the 
molecular ion at m/z 415 were observed in the ESI-MS 
spectrum of the control sample at m/z 380, 279, 272, 255, 
206, 190, 161, 153, 147, 135, 121, and 105, due to the 
successive removal of water and alkyl groups from [M + H]
+ 
and consequently, the internal molecular rearrangement, 
corresponded to the following proposed molecular formula 
C12H20MgO12
+
, C8H15MgO9
+
, C9H12MgO8
+
, C8H7MgO8
+
, 
C8H6MgO5
2+
, C6H6O7
+
, C6H9O5
+
, C5H13O5
+
, C5H7O5
+
, 
C5H11O4
+
, C4H9O4
+
, and C4H9O3
+
, respectively as shown in 
Figure 4. The peak at m/z 431, which was due to the 
magnesium gluconate adduct with the ammonium ion was 
only found in the control sample. This ammonium adduct 
formation might be due to the usage of ammonium acetate 
with water as mobile phase [47, 48]. The other major ions in 
the higher m/z region of the control ESI-MS spectrum 
(Figure 2) were found at m/z 613, 643 and 665. These mass 
indicated for the mass of the magnesium gluconate chelate 
with one gluconate ion through coordinate covalent bond 
(C18H33MgO21, 609) as shown in Figure 4. But it existed in 
three different pseudo-molecular ions. First pseudo-
molecular ion was at m/z 613 (calcd for C18H37MgO21
4+
, 
613). The second pseudo-molecular ion was due to the 
adduct formation with methanol at m/z 643 (calcd for 
C19H38MgO22
+
, 643). The last pseudo-molecular ion was at 
m/z 665 (calcd for C19H37Mg2O22
+
, 665) due to the adduct 
formation of C18H33MgO21 with one Mg
++
 atom as well as 
with methanol. Consequently, the characteristic fragment ion 
peaks in the ESI-MS spectrum of Biofield Energy Treated 
sample were observed at m/z 387, 357, 284, 272, 219, 197, 
179, 147, 133, 115, and 100, which corresponded to the 
following proposed molecular formula C12H27MgO12
+
, 
C11H25MgO11
+
, C8H20MgO9
+
, C9H12MgO8
+
, C6H11MgO7
+
, 
C6H13O7
+
, C6H11O6
+
, C5H7O5
+
, C5H9O4
+
, C4H3O4
+
, and 
C4H4O3
2+
 respectively (Figure 4). The prominent ions 
observed in the higher m/z region of the Biofield Energy 
Treated ESI-MS spectrum (Figure 2) were at m/z 611 and 
643 corresponding to the molecular formula C18H35MgO21
+
 
and C19H38MgO22
+
 that was due to the magnesium gluconate 
chelate with one gluconate ion. 
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Figure 4. Proposed fragmentation pathway of magnesium gluconate. 
Similarly, the ESI-MS (-ve ion mode) spectra of 
magnesium gluconate of both the control and Biofield 
Energy Treated samples found at Rt of 1.8 minutes revealed 
the presence of gluconate ion at m/z 195 [M - H]
-
 (calculated 
for C6H11O7
-
) 195 with 100% base peak intensity. A dimeric 
form of the gluconate ion was found at m/z 391 [2M - H]
-
 
(calculated for C12H23O14
-
, 391) both in the control and 
Biofield Energy Treated samples. Overall, from the above 
data, it can be concluded that the fragmentation pattern of the 
Biofield Energy Treated magnesium gluconate was 
significantly altered compared with the control sample. From 
the analysis, the pseudo molecular ion formation found less 
in case of the Biofield Energy Treated sample compared with 
the control sample in solution. 
3.2. Isotopic Abundance Ratio Analysis 
The molecular formula of magnesium gluconate is 
C12H22MgO14. The LC-MS spectra of both the control and 
Biofield Energy Treated samples indicated the presence of 
the mass for protonated molecular ion at m/z 415 
(C12H23MgO14
+
) showing 53.31% (control) and 48.73% 
(Biofield Energy Treated) relative intensity. The relative 
abundances of an isotopic peak are the contributions of 
several different isotopes and its composition to the same 
peak [43]. The theoretical calculation of PM+1 for the 
protonated magnesium gluconate was presented as below: 
P (
13
C) = [(12 x 1.1%) x 53.31% (the actual size of the M
+
 
peak)] / 100% = 7.04% 
P (
2
H) = [(23 x 0.015%) x 53.31%] / 100%= 0.18% 
P (
17
O) = [(14 x 0.04%) x 53.31%] / 100% = 0.30% 
P (
25
Mg) = [(1 x 12.66%) x 53.31%] / 100% = 6.75% 
PM+1 i.e. 
13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
C12H23MgO14
+
 to m/z 416 = 14.27% 
Thus, the probability to A + 1 elements having an isotope 
that has one mass unit heavier than the most abundant 
isotope (i.e. 
13
C, 
2
H, 
17
O, and 
25
Mg) contributions to the mass 
of the isotopic molecular ion [(M+1)
+
]. In general, the 
deuterium did not contribute much to any isotopic mass, 
because the natural abundance of deuterium is too small 
relative to the natural abundances of carbon, oxygen and 
magnesium isotopes [43-45]. Hence, 
13
C and 
25
Mg have the 
major contributions from magnesium gluconate and 
magnesium gluconate to the isotopic peaks. The percentage 
change in isotopic abundance ratio of PM+1/PM for 
magnesium gluconate in the Biofield Energy Treated and 
control samples are presented in Table 2. The isotopic 
abundance ratio of PM+1/PM in the Biofield Energy Treated 
magnesium gluconate was decreased by 79.24% compared 
with the control sample (Table 2). 
13
C and 
25
Mg contributions 
from C12H23MgO14
+
 to m/z 415 in the Biofield Energy 
Treated sample were reduced compared with the control 
sample. 
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Table 2. Isotopic abundance analysis result of the control and Biofield 
Energy Treated magnesium gluconate. 
Parameter 
Control 
sample 
Biofield Energy 
Treated sample 
PM at m/z 415 (%) 53.31 48.73 
PM+1 at m/z 416 (%) 28.25 5.36 
PM+1/PM 0.5299 0.1100 
% Change of isotopic abundance ratio 
(PM+1/PM) with repect to the control sample 
 -79.24 
PM: the relative peak intensity of the parent molecular ion [M
+]; PM+1: the 
relative peak intensity of the isotopic molecular ion [(M+1)+]. 
The gluconic acid ion (C6H11O7
-
), in the control and 
Biofield Energy Treated sample showed 100% relative peak 
intensity. The abundance of parent molecular ion (PM) was at 
m/z 196, and its size was determined solely by the most 
abundant element composition. PM+1 can be calculated 
theoretically and described below: 
P (
13
C) = [(6 x 1.1%) x 100% (the actual size of the M
+
 
peak)] / 100% = 6.60% 
P (
2
H) = [(11 x 0.015%) x 100%] / 100%= 0.17% 
P (
17
O) = [(7 x 0.04%) x 100%] / 100% = 0.28% 
PM+1 i.e. 
13
C, 
2
H, and 
17
O contributions from (C6H11O7)
+
 to 
m/z 196 = 7.05% 
The calculated abundance of PM+1 (7.05%) in magnesium 
gluconate closely matched to the experimental value obtained 
in the control sample (Table 3). The isotopic abundance ratio 
of PM+1/PM in the gluconate ion was significantly decreased 
by 6.62% in the Biofield Energy Treated sample compared 
with the control sample. Hence, 
13
C, 
2
H, and 
17
O 
contributions from (C6H11O7)
+
 to m/z 196 was decreased in 
the Biofield Energy Treated sample compared with the 
control sample. 
Table 3. LC-MS isotopic abundance analysis result of gluconate ion from the 
control and Biofield Energy Treated samples. 
Parameter 
Control 
sample 
Biofield Energy 
Treated sample 
PM at m/z 195 (%) 100 100 
PM+1 at m/z 196 (%) 7.55 7.05 
PM+1/PM 0.0755 0.0705 
% Change of isotopic abundance ratio 
(PM+1/PM) with repect to the control sample 
 -6.62 
PM: the relative peak intensity of the parent molecular ion [M
+]; PM+1: the 
relative peak intensity of the isotopic molecular ion [(M+1)+]. 
Briefly,
 13
C, 
2
H, 
17
O, and 
25
Mg contributions from 
(C12H23MgO14)
+
 to m/z 416 in the Biofield Energy Treated 
sample was significantly decreased with respect to the control 
sample. 
13
C, 
2
H, and 
17
O contributions from (C6H11O7)
+
 to m/z 
196 was also decreased in the Biofield Energy Treated sample 
comparison with the control sample. Overall, the isotopic 
abundance ratio of PM+1/PM
 
(
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) in the Biofield Energy Treated magnesium 
gluconate was significantly decreased compared with the 
control sample. The alteration in the isotopic abundance ratio 
could be due to the Biofield Energy Healing Treatment. 
Scientific literature reported that the vibrational energy is 
closely related with the reduced mass (µ) of the compound 
and the alteration of the vibrational energy can affect the 
several characteristics like physicochemical, thermal 
properties of the molecule [37, 38, 52, 53]. Replacement of 
the isotopic composition of the magnesium gluconate 
significantly alters the vibrational energy [41, 52, 53]. The 
vibrational energy depends on the reduced mass (µ) for a 
diatomic molecule as shown below (equation 2): 
 = 	                                        (2) 
Where, E0 = the vibrational energy of a harmonic 
oscillator at absolute zero or zero point energy; f = force 
constant 
μ = reduced	mass = 	 + 	 
Where ma and mb are the masses of the constituent atoms. 
The reduced mass (µ) of some of the probable isotopic 
bonds were calculated for magnesium gluconate and its 
possible fragmentations, and the results showed that µ of 
heavier isotopes [i.e. 
13
C-
12
C (µ=6.24),
 2
H-
12
C (µ=1.71), 
16
O-
13
C (µ=7.17), 
17
O-
12
C (µ=7.03), 
16
O-
2
H (µ=1.78), 
25
Mg-
16
O 
(µ=9.76), and
 24
Mg-
17
O (µ=9.95), etc.] were increased than 
the normal bond [i.e. 
12
C-
12
C (µ=6), 
1
H-
12
C (µ=0.92), 
16
O-
12
C 
(µ=6.86), 
16
O-
1
H (µ=0.94) and 
24
Mg-
16
O (µ=9.60)] (Table 4). 
Table 4. Possible isotopic bonds, reduced mass and their effect on the 
vibrational energy in magnesium gluconate. 
Isotope bond Isotope type 
Reduced mass (µ) 
(mA.mB /(mA + mB) 
Zero point vibrational 
energy (E0) 
12C-12C Lighter 6.00 Higher 
13C-12C Heavier 6.26 Smaller 
1H-12C Lighter 0.92 Higher 
2H-12C Heavier 1.04 Smaller 
16O-12C Lighter 6.86 Higher 
16O-13C Heavier 7.17 Smaller 
17O-12C Heavier 7.03 Smaller 
16O-1H Lighter 0.94 Higher 
16O-2H Heavier 1.78 Smaller 
24Mg-16O Lighter 9.60 Higher 
25Mg-16O Heavier 9.76 Smaller 
24Mg-17O Heavier 9.95 Smaller 
mA: mass of atom A; mB: mass of atom B, here A and B may be C or H or O 
or Mg. 
The alteration in the isotopic abundance ratio of 
13
C/
12
C 
for C-O; 
2
H/
1
H for C-H and O-H bonds; 
17
O/
16
O for C-O 
bond; 
25
Mg/
24
Mg, and
 17
O/
16
O for Mg-O bond has the 
significant impact on the ground state vibrational energy of 
the molecule due to the higher reduced mass (µ) as shown in 
the Table 4 that leads to the isotope effects of the molecule. 
Mass spectroscopic analysis of the several organic 
compounds revealed that the isotopic abundance of [M+1]
+
 
ions were decreased, thereby suggesting the change in 
number of neutrons in the molecule. It was then postulated to 
the alterations in atomic mass and atomic charge through the 
possible mediation of neutrino oscillation [52-54]. Thus, it is 
assumed that The Trivedi Effect
®
 - Biofield Energy Healing 
might provide the required energy for the neutrino 
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oscillations. The changes of neutrinos inside the molecule in 
turn modified the particle size, chemical reactivity, density, 
thermal behavior, selectivity, binding energy, etc. [44, 54]. 
Kinetic isotope effect that is resultant from the variation in 
the isotopic abundance ratio of one of the atoms in the 
reactants in a chemical reaction is very useful to study the 
reaction mechanism as well as for understanding the 
enzymatic transition state and all aspects of enzyme 
mechanisms that is supportive for designing enormously 
effective and specific inhibitors [41, 49, 51]. As magnesium 
is an essential cofactor for various enzymatic reactions, the 
Biofield Energy Treated magnesium gluconate that had 
altered isotopic abundance ratio might be useful for the study 
of enzyme mechanism as well as assist in the designing of 
novel potent enzyme inhibitors. 
3.3. Nuclear Magnetic Resonance Spectroscopy (
1
H and 
13
C 
NMR) Analysis 
The 
1
H and 
13
C NMR spectra of the control and Biofield 
Energy Treated magnesium gluconate are shown in Figures 
5a-d. NMR assignments of the control and Biofield Energy 
Treated magnesium gluconate are presented in the Table 5. 
The structure of magnesium gluconate contain a large number 
of OH groups and the hydroxyl protons have no signal in the 
1
H NMR spectra because these protons are replaced by 
deuterium when deuterated water (D2O) was used as solvent 
for spectra recording The signals for the protons signals for 
CH2 and CH groups of the control and Biofield Energy 
Treated magnesium gluconate were in the range of δ 3.54-4.06 
ppm and δ 3.54-4.07 ppm respectively, which complies the 
reported proton spectrum of sodium gluconate [46]. 
Table 5. 1H and 13C NMR assignments of the both control and Biofield Energy Treated of magnesium gluconate. 
s: singlet; br: broad; m: multiplet; * these assignments can be switched. 
The signals for the carbon signals for CO, CH2, and CH 
groups in the 
13
C NMR spectra of the control and Biofield 
Energy Treated magnesium gluconate were in the range of δ 
62.60-178.44 ppm and δ 62.43-178.44 ppm, respectively. 
Thus, the proton and carbon signals for CH, CH2 and CO 
groups in the proton and carbon NMR spectra of the control 
and the Biofield Energy Treated samples were found almost 
similar. It was then concluded that the structure of the 
magnesium gluconate was remained unaltered due to the 
Biofield Energy Healing Treatment. 
 
Figure 5. 1H NMR spectra of the (a) control, (b) the Biofield Energy Treated, 13C NMR spectra of the (c) control, and (d) the Biofield Energy Treated 
magnesium gluconate. 
Position 
1H NMR δ (ppm) 13C NMR δ (ppm) 
Number Control Biofield Energy Treated Control Biofield Energy Treated 
1, 1ꞌ 4H* 
3.74 (br s) 3.73 (br s) 
62.60 62.43 
3.54-3.59 (2H*, m) 3.54-3.57 (2H*, m) 
2, 2ꞌ 2H* 3.67 (br s) 3.66 (br s) 70.84 70.67 
3, 3ꞌ 2H* 3.71 (br s) 3.69 (br s) 71.17 70.96 
4, 4ꞌ 2H 3.95 (br s) 3.95 (br s) 72.42 72.24 
5, 5ꞌ 2H 4.06 (br s) 4.07 (br s) 74.01 73.90 
6, 6ꞌ -- -- -- 178.44 178.38 
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4. Conclusions 
LC-ESI-MS analysis indicated that magnesium gluconate 
in the solution might be existed in situ of three forms, 
magnesium gluconate, gluconic acid and a chelate form of 
magnesium gluconate with the gluconic acid by the 
coordinate covalent bond. The total ion chromatogram (TIC) 
of the control sample showed two peaks at Rt of 1.81 and 
2.06 minutes, whereas The Trivedi Effect
®
 treated sample 
displayed these peaks at Rt of 1.79 and 2.04 minutes. The 
ESI-MS spectra of the control and the treated samples 
revealed the presence of the mass for magnesium gluconate 
ion in two forms at m/z 447 (adduct form with methanol) and 
415 (protonated ion) in positive ionization mode. But, it 
showed the mass for the gluconate ion at m/z 195 in the 
negative ionization mode. The fragmentation pattern of 
magnesium gluconate in the treated sample was significantly 
altered as compared to the control sample. Consequently, the 
LC-ESI-MS based isotopic abundance ratio analysis 
indicated that the PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O or 
25
Mg/
24
Mg) in the Biofield Energy Treated magnesium 
gluconate ion at m/z 415 was significantly decreased by 
79.24% compared with the control sample. Similarly, the 
isotopic abundance ratio of PM+1/PM (
2
H/
1
H or 
13
C/
12
C or 
17
O/
16
O) in gluconate was decreased by 6.62% in the treated 
sample compared with the control sample. Briefly,
 13
C, 
2
H, 
17
O, and 
25
Mg contributions from (C12H23MgO14)
+
 to m/z 416 
in the Biofield Energy Treated sample was significantly 
decreased with respect to the control sample. 
13
C, 
2
H, and 
17
O 
contributions from (C6H11O7)
+
 to m/z 196 was also decreased 
in the treated sample in comparison with the control sample. 
The treated sample might exhibit isotope effects such as 
altered physicochemical and thermal properties, rate of the 
reaction, selectivity and binding energy due to its changed 
isotopic abundance ratio of PM+1/PM compared with the 
control sample. The treated magnesium gluconate might be 
helpful to understand the enzymatic reactions as well as 
design the novel potent enzyme inhibitors by using its kinetic 
isotope effects. Besides, The Trivedi Effect
® 
- Energy of 
Consciousness Healing Treatment, could be a useful 
approach in the design of better nutraceutical and/or 
pharmaceutical formulations that can offer significant 
therapeutic responses against various diseases such as 
diabetes mellitus, allergies and septic shock, stress-related 
disorders like sleep disorder, insomnia, anxiety, depression, 
Attention Deficit Disorder (ADD), Attention Deficit 
Hyperactive Disorder (ADHD), mental restlessness (mind 
chattering), brain frog, low libido, impotency, lack of 
motivation, mood swings, fear of the future, confusion, 
migraines, headaches, forgetfulness, overwhelm, loneliness, 
worthlessness, indecisiveness, frustration, irritability, chronic 
fatigue, obsessive/compulsive behavior and panic attacks, 
inflammatory diseases and immunological disorders like 
Lupus, Systemic Lupus Erythematosus, Hashimoto 
Thyroiditis, Type 1 Diabetes, Asthma, Chronic peptic ulcers, 
Tuberculosis, Hepatitis, Chronic active hepatitis, Celiac 
Disease (gluten-sensitive enteropathy), Addison Disease, 
Crohn's disease, Graves’ Disease, Pernicious and Aplastic 
Anemia, Sjogren Syndrome, Irritable Bowel Syndrome 
(IBS), Multiple Sclerosis, Rheumatoid arthritis, Chronic 
periodontitis, Ulcerative colitis, Chronic sinusitis, 
Myasthenia Gravis, Atherosclerosis, Vasculitis, Dermatitis, 
Diverticulitis, Rheumatoid Arthritis, Reactive Arthritis, 
Alopecia Areata, Psoriasis, Scleroderma, Fibromyalgia, 
Chronic Fatigue Syndrome and Vitiligo, aging-related 
diseases like cardiovascular disease, arthritis, cancer, 
Alzheimer’s disease, dementia, cataracts, osteoporosis, 
diabetes, hypertension, glaucoma, hearing loss, Parkinson’s 
Disease, Huntington’s Disease, Prion Disease, Motor 
Neurone Disease, Spinocerebellar Ataxia, Spinal muscular 
atrophy, Amyotrophic lateral sclerosis, Friedreich’s Ataxia 
and Lewy Body Disease; chronic infections and much more. 
Abbreviations 
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ionization; IAR: Isotopic abundance ratio; LC-MS: Liquid 
chromatography-mass spectrometry, PDA: Photodiode 
Array; NMR: Nuclear magnetic resonance spectroscopy; PM: 
The relative peak intensity of the parent molecular ion [M
+
]; 
PM+1: The relative peak intensity of isotopic molecular ion 
[(M+1)
+
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